Structures by: Bouzian Y.
Total: 7
Ethyl 2-{[2-(2-ethoxy-2-oxoethoxy)quinolin-4-yl]carbonyloxy}acetate
C18H19NO7
IUCrData (2018) 3, 10 x181438
a=4.9417(2)Å b=7.6157(3)Å c=23.4472(9)Å
α=94.490(2)° β=92.997(2)° γ=98.136(2)°
1-Ethyl-4-phenyl-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C17H16N2O
IUCrData (2016) 1, 4 x160661
a=16.5042(4)Å b=9.6896(3)Å c=18.1221(5)Å
α=90° β=90° γ=90°
2-(2-Oxo-1,3-oxazolidin-3-yl)ethyl 2-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]quinoline-4-carboxylate
C20H21N3O7
Acta Crystallographica Section E (2021) 77, 1 28-33
a=6.0686(5)Å b=19.2791(15)Å c=16.3795(13)Å
α=90° β=94.185(4)° γ=90°
Hexyl 1-hexyl-2-oxo-1,2-dihydroquinoline-4-carboxylate
C22H31NO3
Acta Crystallographica Section E (2020) 76, 5 642-645
a=17.6928(7)Å b=13.2512(5)Å c=8.5916(3)Å
α=90° β=90.184(2)° γ=90°
(2<i>Z</i>)-2-(2,4-Dichlorobenzylidene)-4-[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C20H16Cl2N2O3S
Acta Crystallographica Section E (2019) 75, 5 593-599
a=18.4615(8)Å b=12.8567(5)Å c=7.9251(4)Å
α=90° β=96.926(2)° γ=90°
Enzyl 1-benzyl-2-oxo-1,2-dihydroquinoline-4-carboxylate
C24H19NO3
Acta Crystallographica Section E (2019) 75, 7 980-983
a=5.6101(4)Å b=19.5523(11)Å c=17.2761(11)Å
α=90° β=96.969(5)° γ=90°
Ethyl 6-chloro-2-ethoxyquinoline-4-carboxylate
C14H14ClNO3
Acta Crystallographica Section E (2019) 75, 6 912-916
a=14.2634(7)Å b=16.0124(7)Å c=13.7732(6)Å
α=90° β=117.748(2)° γ=90°